Massive Upside In Big Money Pharma Favorite?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes in the use of immune therapies for cancer treatment. Specifically, Iovance is exploring new applications of tumor infiltrating lymphocyte (TIL) therapy, utilizing cells that the human body naturally produces to attack cancerous tumors.
There was lots of hype about this next-generation cancer treatment company but its share price has been decidedly lackluster this year, » Read more about: Massive Upside In Big Money Pharma Favorite? »
Read More
How Far Will The Market Fall?
Zooming out is often quite helpful in providing insights as to where the market is likely to go. When we examine a chart of the S&P 500 now on a weekly basis, a clear uptrend from mid-2022 has formed.
So too has a strong resistance line been created at close to the 4,800 mark both at the end of 2021 and the end of 2023.
» Read more about: How Far Will The Market Fall? »
Read More
Stock Market Riddle Reveals Big Opportunity
Imagine a company generating $210 billion in revenues, what do you think it would be worth? To give you a clue, Alphabet produces $297 billion in revenues and is worth almost $1.8 billion. Can you take a stab now at what this other firm is worth?
There is lots of information you need to answer the question so we’ll cut to the chase and share with you that the company in question,
» Read more about: Stock Market Riddle Reveals Big Opportunity »
Read More
Smartest AI Stock to Buy Now
It’s easy to get caught up in the hype of Nvidia but perhaps the smartest stock to buy now is Alphabet (GOOGL). Across the gamut of products and services offered by Alphabet, a whole new world of revenues opens up when AI is factored in.
We delve in to explore just how large the opportunity is for Alphabet and potentially for shareholders over the next few years.
» Read more about: Smartest AI Stock to Buy Now »
Read More
1 Cloud SaaS Healthcare Stock to Buy on the Dip?
It might surprise many that Veeva Systems Inc. (NYSE:VEEV), best known for its cloud-based software solutions tailored to the life sciences industry, has maintained a core principle of putting customer success and product excellence ahead of short-term gains.
In a market crowded with SaaS companies seeking to serve a wide variety of enterprises,
» Read more about: 1 Cloud SaaS Healthcare Stock to Buy on the Dip? »
Read MoreThe Ivy
How High Can NVIDIA Go In 5 Years?
NVIDIA (NASDAQ:NVDA) has been by far one of the best stocks to hold over the last several years. Surging demand for AI data center chips has caused sales of the company’s GPUs to skyrocket, leading to explosive growth and massive returns for investors.
The question now, though, is whether the future will be as good to NVIDIA as the past few years have been.
» Read more about: How High Can NVIDIA Go In 5 Years? »
Read MoreThe Spotlight
1 Money-Making Stock Investors Are Sleeping On
ResMed might not be a household name for the average investor, but its portfolio of almost 6,000 patents focused on sleep apnea and respiratory care suggest perhaps it should be. The IP forms an economic moat for ResMed in the medical devices industry, which is massive.
One of the key factors attracting investors to ResMed is the booming sleep apnea devices market,
» Read more about: 1 Money-Making Stock Investors Are Sleeping On »
Read MoreThe Daily
Trump's 2025 financial disclosure reveals president made $57 million from cryptocurrency startup
President Donald Trump’s most recent financial disclosure form that was filed Friday saw the commander-in-chief rake in over $57 million from his share in the cryptocurrency start-up, World Liberty Financial.
The World Liberty Financial platform was launched by the Trump family last year, and the president’s sons,